Catalysis is crucial in the context of Gaucher disease because the condition stems directly from a catalytic deficiency. The enzyme glucocerebrosidase normally acts as a catalyst in the biochemical pathway that breaks down glucocerebroside. When this catalytic function is impaired due to genetic mutations, the substrate accumulates, leading to the pathology observed in Gaucher disease.
